Ignite Creation Date:
2024-05-05 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 9:53 AM
Study NCT ID:
NCT00728546
Status:
UNKNOWN
Last Update Posted:
2012-12-27
First Post:
2008-08-01
Brief Title:
NAT2 in Re-challenge of INH in Patients With Hepatitis
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
The Application of the N-acetyltransferase 2 NAT2 Genotyping in Re-challenge Protocol of Isoniazid INH Titration in Patients With Anti-TB Medications-induced Hepatitis
Status:
UNKNOWN
Status Verified Date:
2012-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Apply the information of NAT2 genotyping into the re-challenge protocol of INH titration in patients with anti-TB medication induced hepatitis
Detailed Description:
adjusting INH dose according to NAT2 genotyping and serum concentration of INH
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None